Table of Contents Global Gynecological Cancers Drug Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Gynecological Cancers Drug Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Gynecological Cancers Drug Segment by Type 1.2.1 Uterine 1.2.2 Ovarian Cancer 1.2.3 Vaginal Cancer 1.2.4 Vulvar Cancer 1.2.5 Cervical Cancer 1.3 Market Analysis by Application 1.3.1 Hospitals 1.3.2 Drug Shops 1.3.3 Other 1.4 Overview of Global Gynecological Cancers Drug Market 1.4.1 Global Gynecological Cancers Drug Revenue (2015-2025) 1.4.2 Global Gynecological Cancers Drug Production and Capacity (2015-2025) 1.4.3 North America Gynecological Cancers Drug Status and Prospect (2015-2025) 1.4.4 Europe Gynecological Cancers Drug Status and Prospect (2015-2025) 1.4.5 Japan Gynecological Cancers Drug Status and Prospect (2014-2025) 1.4.6 China Gynecological Cancers Drug Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Gynecological Cancers Drug Industry Impact 1.6.1 How the Covid-19 is Affecting the Gynecological Cancers Drug Industry 1.6.2 Gynecological Cancers Drug Business Impact Assessment - Covid-19 1.6.3 Market Trends and Gynecological Cancers Drug Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Gynecological Cancers Drug Market Competition by Manufacturer 2.1 Global Gynecological Cancers Drug Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Gynecological Cancers Drug Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Gynecological Cancers Drug Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Gynecological Cancers Drug Manufacturer Market Share 2.5 Top 10 Gynecological Cancers Drug Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Gynecological Cancers Drug Market 2.7 Key Manufacturers Gynecological Cancers Drug Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Gynecological Cancers Drug Industry Key Manufacturers 3.1 GlaxoSmithKline plc 3.1.1 Company Details 3.1.2 Product Information 3.1.3 GlaxoSmithKline plc Gynecological Cancers Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 GlaxoSmithKline plc News 3.2 Becton Dickinson 3.2.1 Company Details 3.2.2 Product Information 3.2.3 Becton Dickinson Gynecological Cancers Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 Becton Dickinson News 3.3 Eli Lilly 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Eli Lilly Gynecological Cancers Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Eli Lilly News 3.4 Bristol Myers Squibb Co 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Bristol Myers Squibb Co Gynecological Cancers Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Bristol Myers Squibb Co News 3.5 Hoffmann La Roche Ltd 3.5.1 Company Details 3.5.2 Product Information 3.5.3 Hoffmann La Roche Ltd Gynecological Cancers Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 Hoffmann La Roche Ltd News 4 Global Gynecological Cancers Drug Market Size Categorized by Regions (2015-2020) 4.1 Global Gynecological Cancers Drug Sales Market Share by Region 4.2 Global Gynecological Cancers Drug Revenue Market Share by Region (2015-2019) 4.3 Global Gynecological Cancers Drug Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Gynecological Cancers Drug Market Size Detail 4.4.1 North America Gynecological Cancers Drug Sales Growth Rate (2015-2020) 4.4.2 North America Gynecological Cancers Drug Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Gynecological Cancers Drug Market Size Detail 4.5.1 Europe Gynecological Cancers Drug Sales Growth Rate (2015-2020) 4.5.2 Europe Gynecological Cancers Drug Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Gynecological Cancers Drug Market Size Detail 4.6.1 Japan Gynecological Cancers Drug Sales Growth Rate (2015-2020) 4.6.2 Japan Gynecological Cancers Drug Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Gynecological Cancers Drug Market Size Detail 4.7.1 China Gynecological Cancers Drug Sales Growth Rate (2015-2020) 4.7.2 China Gynecological Cancers Drug Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Gynecological Cancers Drug Market Segment by Type 5.1 Global Gynecological Cancers Drug Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Gynecological Cancers Drug Sales and Market Share by Type (2015-2020) 5.1.2 Global Gynecological Cancers Drug Revenue and Market Share by Type (2015-2020) 5.2 Uterine Sales Growth Rate and Price 5.2.1 Global Uterine Sales Growth Rate (2015-2020) 5.2.2 Global Uterine Price (2015-2020) 5.3 Ovarian Cancer Sales Growth Rate and Price 5.3.1 Global Ovarian Cancer Sales Growth Rate (2015-2020) 5.3.2 Global Ovarian Cancer Price (2015-2020) 5.4 Vaginal Cancer Sales Growth Rate and Price 5.4.1 Global Vaginal Cancer Sales Growth Rate (2015-2020) 5.4.2 Global Vaginal Cancer Price (2015-2020) 5.5 Vulvar Cancer Sales Growth Rate and Price 5.5.1 Global Vulvar Cancer Sales Growth Rate (2015-2020) 5.5.2 Global Vulvar Cancer Price (2015-2020) 5.6 Cervical Cancer Sales Growth Rate and Price 5.6.1 Global Cervical Cancer Sales Growth Rate (2015-2020) 5.6.2 Global Cervical Cancer Price (2015-2020) 6 Global Gynecological Cancers Drug Market Segment by Application 6.1 Global Gynecological Cancers Drug Sales Market Share by Application (2015-2020) 6.2 Hospitals Sales Growth Rate (2015-2020) 6.3 Drug Shops Sales Growth Rate (2015-2020) 6.4 Other Sales Growth Rate (2015-2020) 7 Gynecological Cancers Drug Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Gynecological Cancers Drug Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Gynecological Cancers Drug Market Forecast 8.1 Global Gynecological Cancers Drug Sales, Revenue Forecast 8.1.1 Global Gynecological Cancers Drug Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Gynecological Cancers Drug Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Gynecological Cancers Drug Price and Trend Forecast (2020-2025) 8.2 Global Gynecological Cancers Drug Sales Forecast by Region (2020-2025) 8.2.1 North America Gynecological Cancers Drug Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Gynecological Cancers Drug Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Gynecological Cancers Drug Production, Revenue Forecast (2020-2025) 8.2.4 China Gynecological Cancers Drug Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Gynecological Cancers Drug Picture Table Global Gynecological Cancers Drug Sales by Type Figure Global Sales Market Share of Gynecological Cancers Drug by Product Type in 2019 Table Breakdown of Gynecological Cancers Drug by Company Type (Tier 1, Tier 2 and Tier 3) Figure Gynecological Cancers Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Uterine Picture Figure Ovarian Cancer Picture Figure Vaginal Cancer Picture Figure Vulvar Cancer Picture Figure Cervical Cancer Picture Table Global Gynecological Cancers Drug Sales by Application Figure Global Gynecological Cancers Drug Sales Market Share by Application in 2019 Figure Hospitals Picture Figure Drug Shops Picture Figure Other Picture Table Gynecological Cancers Drug Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Gynecological Cancers Drug Revenue (Million US$) (2015-2025) Figure Global Gynecological Cancers Drug Production (K Units) (2015-2025) Figure North America Gynecological Cancers Drug Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Gynecological Cancers Drug Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Gynecological Cancers Drug Revenue (Million US$) Growth Rate (2014-2025) Figure China Gynecological Cancers Drug Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Gynecological Cancers Drug Sales by Manufacturer (2018-2020) Figure Global Gynecological Cancers Drug Sales Market Share by Manufacturer in 2019 Table Global Gynecological Cancers Drug Revenue by Manufacturer (2018-2020) Figure Global Gynecological Cancers Drug Revenue Market Share by Manufacturer in 2019 Table Global Gynecological Cancers Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Gynecological Cancers Drug Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Gynecological Cancers Drug Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Gynecological Cancers Drug Market Table Key Manufacturers Gynecological Cancers Drug Product Type Table Mergers & Acquisitions Planning Table GlaxoSmithKline plc Company Profile Figure Gynecological Cancers Drug Product Picture and Specifications of GlaxoSmithKline plc Table Gynecological Cancers Drug Production, Price, Revenue and Gross Margin of 2018-2020 Figure GlaxoSmithKline plc Gynecological Cancers Drug Market Share (2018-2020) Table GlaxoSmithKline plc Main Business Table GlaxoSmithKline plc Recent Development Table Becton Dickinson Company Profile Figure Gynecological Cancers Drug Product Picture and Specifications of Becton Dickinson Table Gynecological Cancers Drug Production, Price, Revenue and Gross Margin of 2018-2020 Figure Becton Dickinson Gynecological Cancers Drug Market Share (2018-2020) Table Becton Dickinson Main Business Table Becton Dickinson Recent Development Table Eli Lilly Company Profile Figure Gynecological Cancers Drug Product Picture and Specifications of Eli Lilly Table Gynecological Cancers Drug Production, Price, Revenue and Gross Margin of 2018-2020 Figure Eli Lilly Gynecological Cancers Drug Market Share (2018-2020) Table Eli Lilly Main Business Table Eli Lilly Recent Development Table Bristol Myers Squibb Co Company Profile Figure Gynecological Cancers Drug Product Picture and Specifications of Bristol Myers Squibb Co Table Gynecological Cancers Drug Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bristol Myers Squibb Co Gynecological Cancers Drug Market Share (2018-2020) Table Bristol Myers Squibb Co Main Business Table Bristol Myers Squibb Co Recent Development Table Hoffmann La Roche Ltd Company Profile Figure Gynecological Cancers Drug Product Picture and Specifications of Hoffmann La Roche Ltd Table Gynecological Cancers Drug Production, Price, Revenue and Gross Margin of 2018-2020 Figure Hoffmann La Roche Ltd Gynecological Cancers Drug Market Share (2018-2020) Table Hoffmann La Roche Ltd Main Business Table Hoffmann La Roche Ltd Recent Development Table Global Gynecological Cancers Drug Sales (K Units) by Region (2015-2020) Table Global Gynecological Cancers Drug Sales Market Share by Region (2015-2019) Figure Global Gynecological Cancers Drug Sales Market Share by Region (2015-2019) Figure Global Gynecological Cancers Drug Sales Market Share by Region in 2018 Table Global Gynecological Cancers Drug Revenue (Million US$) by Region (2015-2020) Table Global Gynecological Cancers Drug Revenue Market Share by Region (2015-2020) Figure Global Gynecological Cancers Drug Revenue Market Share by Region (2015-2020) Figure Global Gynecological Cancers Drug Revenue Market Share by Region in 2019 Table Global Gynecological Cancers Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Gynecological Cancers Drug Sales (K Units) Growth Rate (2015-2020) Figure Europe Gynecological Cancers Drug Sales (K Units) Growth Rate (2015-2020) Table Europe Gynecological Cancers Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Gynecological Cancers Drug Sales (K Units) Growth Rate (2015-2020) Table Japan Gynecological Cancers Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Gynecological Cancers Drug Sales (K Units) Growth Rate (2015-2020) Table China Gynecological Cancers Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Gynecological Cancers Drug Sales by Type (2015-2020) Table Global Gynecological Cancers Drug Sales Market Share by Type (2015-2020) Figure Global Gynecological Cancers Drug Sales Market Share by Type in 2019 Table Global Gynecological Cancers Drug Revenue by Type (2015-2020) Table Global Gynecological Cancers Drug Revenue Market Share by Type (2015-2020) Figure Global Gynecological Cancers Drug Revenue Market Share by Type in 2019 Figure Global Uterine Sales Growth Rate (2015-2025) Figure Global Uterine Price (2015-2020) Figure Global Ovarian Cancer Sales Growth Rate (2015-2025) Figure Global Ovarian Cancer Price (2015-2020) Figure Global Vaginal Cancer Sales Growth Rate (2015-2025) Figure Global Vaginal Cancer Price (2015-2020) Figure Global Vulvar Cancer Sales Growth Rate (2015-2025) Figure Global Vulvar Cancer Price (2015-2020) Figure Global Cervical Cancer Sales Growth Rate (2015-2025) Figure Global Cervical Cancer Price (2015-2020) Table Global Gynecological Cancers Drug Sales Market Share by Application (2015-2020) Figure Global Gynecological Cancers Drug Sales Market Share by Application in 2019 Figure Global Hospitals Sales Growth Rate (2015-2025) Figure Global Drug Shops Sales Growth Rate (2015-2025) Figure Global Other Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Gynecological Cancers Drug Table Key Players of Downstream Markets Figure Sales Channel Figure Global Gynecological Cancers Drug Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Gynecological Cancers Drug Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Gynecological Cancers Drug Price and Trend Forecast (2020-2025) Table Global Gynecological Cancers Drug Sales (K Units) Forecast by Region (2020-2025) Figure Global Gynecological Cancers Drug Production Market Share Forecast by Region (2020-2025) Figure North America Gynecological Cancers Drug Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Gynecological Cancers Drug Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Gynecological Cancers Drug Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Gynecological Cancers Drug Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Gynecological Cancers Drug Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Gynecological Cancers Drug Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Gynecological Cancers Drug Production (K Units) Growth Rate Forecast (2020-2025) Figure China Gynecological Cancers Drug Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

GlaxoSmithKline plc Becton Dickinson Eli Lilly